[Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections]
Chang-Kuan Fu,Huan Liu,Lian-Xin Wang,Yi-Huai Zou,Ming-Quan Li,Ya-Ming Lin,Wei-Hong Sun,Xu Wei,Yu-Er Hu,Yan-Ming Xie,Yuan-Yuan Li
DOI: https://doi.org/10.19540/j.cnki.cjcmm.20240423.501
Abstract:In 2019, the newly revised Drug Administration Law of the People's Republic of China was issued and implemented,clearly proposing that China should establish a pharmacovigilance system. As a new traditional Chinese medicine(TCM) dosage form created in China, TCM injections have been widely used in clinic, and its pharmacovigilance has attracted much attention. In response to this situation, the project team convened a group of clinical, pharmaceutical and evidence-based medicine experts from all over the country to form an expert group, which formulated the Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections in strict accordance with the requirements of the group standards of the Chinese Association of Chinese Medicine.From the perspective of clinical application and considering the key elements of pharmacovigilance for clinical application of TCM injections, the guidelines put forward suggestions on the decision making of pharmacovigilance for clinical application of TCM injections from four key links, namely the monitoring and reporting, signal recognition, risk assessment and risk control, according to China's pharmacovigilance regulations and learning from foreign pharmacovigilance guidelines.